CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
16.60
-0.56 (-3.26%)
May 13, 2025, 4:00 PM - Market closed
CeriBell Employees
CeriBell had 281 employees as of December 31, 2024. The number of employees increased by 52 or 22.71% compared to the previous year.
Employees
281
Change (1Y)
52
Growth (1Y)
22.71%
Revenue / Employee
$254,573
Profits / Employee
-$159,114
Market Cap
599.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 281 | 52 | 22.71% |
| Dec 31, 2023 | 229 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CBLL News
- 3 days ago - CeriBell, Inc. (CBLL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Ceribell Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 13 days ago - Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 13 days ago - Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - GlobeNewsWire
- 19 days ago - Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 4 weeks ago - FDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - GlobeNewsWire
- 2 months ago - CeriBell, Inc. (CBLL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire